This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview

Prof. dr. Marcel Verheij group


Prof. dr. Marcel Verheij

Group leader

Personal details


Marcel Verheij (1962) received his medical degree in 1989 at the State University in Leiden. Following his Military Service, he joined the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital in Amsterdam where he did his residency in Radiation Oncology. From 1994 until 1996 he spent a KWF fellowship at Memorial Sloan-Kettering Cancer Center as part of his PhD program. Here, he was involved in apoptosis research and studied the role of the stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) signal transduction pathway in radiation-induced apoptosis. In 1996 he received his PhD (cum laude) from the Free University in Amsterdam on Radiation Injury of the Kidney: Mechanisms and Modulation of Endothelial Dysfunction. Since 2000 he is a permanent staff radiation oncologist at the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital where he holds a 50% clinical/50% research position as group leader at the Division of Biological Stress Response. In 2004 he was appointed professor in Translational Radiotherapy at the Free University in Amsterdam and since May 2007 he chairs the Department of Radiotherapy.

Share this page